⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23529719 | 0.76 | — | — | |
| SCHEMBL1205841 | 0.73 | — | — | |
| SCHEMBL9464881 | 0.73 | — | — | |
| SCHEMBL16248125 | 0.71 | — | — | |
| SCHEMBL174227 | 0.71 | — | — | |
| SCHEMBL28017122 | 0.71 | — | — | |
| SCHEMBL1531192 | 0.71 | — | — | |
| SCHEMBL21737077 | 0.71 | — | — | |
| SCHEMBL22904222 | 0.71 | — | — | |
| SCHEMBL21198241 | 0.70 | SMN1; SMN2 (0.66) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240360135-A1 | IMIDAZO[1,2-B]PYRIDAZINYL COMPOUNDS AND USES THEREOF | SUMITOMO PHARMA ONCOLOGY INC (US) | 2024-10-31 | — | — | US | disclosed |
| WO-2023010102-A1 | IMIDAZO[1,2-B]PYRIDAZINYL COMPOUNDS AND USES THEREOF | SUMITOMO PHARMA ONCOLOGY, INC. (US) | 2023-02-02 | — | — | WO | disclosed |
| WO-2023010102-A1 | IMIDAZO[1,2-B]PYRIDAZINYL COMPOUNDS AND USES THEREOF | SUMITOMO PHARMA ONCOLOGY, INC. (US) | 2023-02-02 | — | — | WO | disclosed |
| CN-105164124-B | Compounds and compositions for treating parasitic diseases | 诺华股份有限公司 | 2017-03-15 | — | — | CN | disclosed |
| CN-105164124-A | Compounds and compositions for treating parasitic diseases | NOVARTIS AG | 2015-12-16 | — | — | CN | disclosed |